Literature DB >> 3125787

Emergence of resistance to imipenem in Pseudomonas aeruginosa.

M J Lynch1, G L Drusano, H L Mobley.   

Abstract

The emergence of resistance to imipenem by Pseudomonas aeruginosa was investigated with four pairs of isolates. Each pair represented pretherapy (susceptible) and posttherapy (resistant) specimens. In all cases, the imipenem-resistant isolates did not demonstrate changed susceptibilities to other beta-lactams. Agarose gel electrophoresis revealed no change in plasmid profiles between any pair of isolates. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the Sarkosyl-insoluble membrane protein revealed the loss of an outer membrane protein of apparent molecular mass 48 to 49 kilodaltons in posttherapy strains when grown with imipenem selection (5 micrograms/ml). There was no significant difference in the binding of [14C]imipenem to the penicillin-binding proteins of the pre- and posttherapy strains. Trichloroacetic acid precipitation of membranes isolated after growth in the presence of [14C]imipenem revealed that significantly less drug was bound to Sarkosyl-soluble membrane protein in three of the four posttherapy strains than the membrane proteins of the respective pretherapy strains. beta-Lactamase activity against imipenem at 100 or 3 microM was not detected in any isolate either with or without induction. These data suggest that resistance to imipenem is associated with the loss of a 48- to 49-kilodalton outer membrane protein accompanied by, in three of four cases, decreased penetration of the antibiotic across the outer membrane.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3125787      PMCID: PMC175822          DOI: 10.1128/AAC.31.12.1892

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections.

Authors:  J P Quinn; E J Dudek; C A DiVincenzo; D A Lucks; S A Lerner
Journal:  J Infect Dis       Date:  1986-08       Impact factor: 5.226

3.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactam.

Authors:  G B Calandra; M Hesney; C Grad
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

Review 6.  In vitro activity of imipenem--a review.

Authors:  I Braveny
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

7.  Correlation between lipopolysaccharide structure and permeability resistance in beta-lactam-resistant Pseudomonas aeruginosa.

Authors:  A J Godfrey; L Hatlelid; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

8.  Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability.

Authors:  H C Neu; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

9.  Pneumonia treated with imipenem/cilastatin.

Authors:  R A Salata; R L Gebhart; D L Palmer; B H Wade; W M Scheld; D H Groschel; R P Wenzel; G L Mandell; R J Duma
Journal:  Am J Med       Date:  1985-06-07       Impact factor: 4.965

10.  Effect of highly potent antipseudomonal beta-lactam agents alone and in combination with aminoglycosides against Pseudomonas aeruginosa.

Authors:  S A Lerner; E J Dudek; W E Boisvert; K D Berndt
Journal:  Rev Infect Dis       Date:  1984 Sep-Oct
View more
  35 in total

1.  Role of putative loops 2 and 3 in imipenem passage through the specific porin OprD of Pseudomonas aeruginosa.

Authors:  M M Ochs; M Bains; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

2.  C-terminal region of Pseudomonas aeruginosa outer membrane porin OprD modulates susceptibility to meropenem.

Authors:  S F Epp; T Köhler; P Plésiat; M Michéa-Hamzehpour; J Frey; J C Pechère
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility.

Authors:  Veronica N Kos; Maxime Déraspe; Robert E McLaughlin; James D Whiteaker; Paul H Roy; Richard A Alm; Jacques Corbeil; Humphrey Gardner
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

4.  Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids.

Authors:  M M Ochs; M P McCusker; M Bains; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

5.  Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa.

Authors:  J Trias; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

6.  In vitro activity of E1040 against imipenem-resistant Pseudomonas aeruginosa strains.

Authors:  M Watanabe; E Inoue; K Katsu; S Iyobe; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1992-03       Impact factor: 5.191

7.  Resistance to pefloxacin in Pseudomonas aeruginosa.

Authors:  M Michea-Hamzehpour; C Lucain; J C Pechere
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

8.  Role of protein F in maintaining structural integrity of the Pseudomonas aeruginosa outer membrane.

Authors:  N Gotoh; H Wakebe; E Yoshihara; T Nakae; T Nishino
Journal:  J Bacteriol       Date:  1989-02       Impact factor: 3.490

9.  Transient carbapenem resistance induced by salicylate in Pseudomonas aeruginosa associated with suppression of outer membrane protein D2 synthesis.

Authors:  Y Sumita; M Fukasawa
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

10.  Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem.

Authors:  E H Lee; M H Nicolas; M D Kitzis; G Pialoux; E Collatz; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.